- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04490356
Enhancing Physical Function in the Long-term for Older Adults
March 29, 2024 updated by: Duke University
Extending Legacy Benefits of Obesity Reduction in Older Adults: A Novel Telehealth Intervention Using Nutrition and Exercise
The intervention being studied is a 12-week nutrition and physical activity intervention, delivered using videoconference technology by registered dietitian clinicians to maintain weight loss and functional gains in older adults who successfully completed a weight loss intervention.
The "Legacy Intervention" will include cognitive behavioral strategies (e.g., goal setting, self-monitoring, and social support), and draw upon a toolbox of e-approaches, including daily and weekly text reminders, virtual exercise classes, virtual individual and group nutrition classes, and step tracking device.
Study Overview
Status
Suspended
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University, School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Participated in a weight loss intervention in the last 9 months and lost ≥ 3% body weight and improved SPPB score by ≥ 1 point or 6MWT by ≥ 50 meters
- Age ≥ 60
- Able to speak and understand spoken and written English.
- Able to record dietary intake and weight
Exclusion Criteria:
- Presence of unstable or symptomatic life-threatening illness
- Neurological conditions causing functional impairment, including Parkinson's disease, multiple sclerosis, and permanent disability due to stroke
- Inability to complete physical function assessment
- No access to internet connection to participate in the tele-intervention
- Unable or unwilling to use provided tablet to participant in tele-intervention
- History of cognitive impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Legacy Intervention
Older adults who have successfully completed a lifestyle intervention (lost at least 3% body weight and increased short physical performance battery (SPPB) score by 1 point or 6-minute walk test (6MWT) by 50 meters) will be enrolled in a tele-nutrition and tele-exercise intervention.
|
The Legacy intervention is a nutrition and exercise protocol delivered using video conference technology.
The Legacy protocol incorporates behavioral strategies along with nutrition and exercise to maintain and extend functional benefits of obesity treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Retention
Time Frame: 12 week endpoint
|
Completion of at least 85% of tele-nutrition and tele-exercise intervention
|
12 week endpoint
|
Acceptability as measured by Participant Satisfaction
Time Frame: 12 week endpoint
|
Participants will asked to rate their satisfaction using a five point likert scale (very dissatisfied; dissatisfied; neutral; satisfied; very satisfied) on a) satisfaction with the delivery of the tele-nutrition intervention, b) satisfaction with the delivery of the tele-exercise intervention c) satisfaction with their ability to maintain their physical function d) satisfaction with their ability to maintain their weight loss e) satisfaction with interactions with the registered dietitian.
|
12 week endpoint
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in physical performance as measured by the Short Physical Performance Battery
Time Frame: 0, 6, 12 weeks
|
Change score of Short Physical Performance Battery score from baseline, 6 and 12 weeks
|
0, 6, 12 weeks
|
Change in physical function as measured using the 6 minute walk test
Time Frame: 0, 6, 12 weeks
|
Change score for distance walked in six minutes from baseline
|
0, 6, 12 weeks
|
Change in body weight as measured by the Aria Fitbit Scale
Time Frame: 0, 6, 12 weeks
|
Change score for body weight from baseline, 6 and 12 weeks
|
0, 6, 12 weeks
|
Change in Body mass as measured by the Aria Fitbit Scale (%)
Time Frame: 0, 6, 12 weeks
|
Change score for percent body mass from baseline, 6 and 12 weeks
|
0, 6, 12 weeks
|
Change in average weekly steps measured using Garmin watch
Time Frame: Every week for 12 weeks
|
Using Garmin watch to determine average weekly step count over 12 weeks study and compare change in weekly step count over time.
|
Every week for 12 weeks
|
Change in total calories using 3-day food record (participants record everything they eat and drink for three days
Time Frame: 0, 6, 12 weeks
|
Change score for total calories will be measured using 3-day food records from baseline, 6 and 12 weeks
|
0, 6, 12 weeks
|
Change in macronutrients using 3-day food record (participants record everything they eat and drink for three days
Time Frame: 0, 6, 12 weeks
|
Macronutrient intake will be measured using 3-day food records from baseline, 6 and 12 weeks
|
0, 6, 12 weeks
|
Change in Stress using the Perceived Stress Scale
Time Frame: 0, 6, 12 weeks
|
Change score for stress from baseline, 6 and 12 weeks.
Perceived Stress Scale is a a 12-item stress assessment instrument.
Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress.
|
0, 6, 12 weeks
|
Change in Self-reported Depression using the Center for Epidemiologic Studies Depression Scale (CES-D)
Time Frame: 0, 6, 12 weeks
|
Change score for self-reported depression from baseline, 6 and 12 weeks.
|
0, 6, 12 weeks
|
Change in Mood using the Profile of Mood States questionnaire
Time Frame: 0, 6, 12 weeks
|
Change score for mood from baseline, 6 and 12 weeks.
Profile of Mood States is a psychological rating scale used to assess transient, distinct mood states that uses a five-point scale ranging from "not at all" to "extremely".
|
0, 6, 12 weeks
|
Change in quality of life using the SF-36 questionnaire
Time Frame: 0, 6, 12 weeks
|
Change score for the Physical and Mental composite scores from baseline 0, 6, and 12 weeks.
|
0, 6, 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kathryn Starr, PhD, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 26, 2021
Primary Completion (Estimated)
March 31, 2025
Study Completion (Estimated)
March 31, 2025
Study Registration Dates
First Submitted
July 24, 2020
First Submitted That Met QC Criteria
July 24, 2020
First Posted (Actual)
July 29, 2020
Study Record Updates
Last Update Posted (Actual)
April 2, 2024
Last Update Submitted That Met QC Criteria
March 29, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO00105630
- 1P30AG064201-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss Maintenance
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Drexel UniversityUniversity of PennsylvaniaCompletedObesity | Overweight | Weight Loss MaintenanceUnited States
-
University of HawaiiQueen's Medical Center; I Ola Lahui, Inc.; Ke Ola Mamo; Queen Lili'uokalani Children... and other collaboratorsCompletedObesity | Overweight | Weight Loss | Weight Loss MaintenanceUnited States
-
Laval UniversityUniversity of OttawaRecruitingWeight Loss | Weight Maintenance | Appetite ControlCanada
-
University of Colorado, DenverCompletedDietary Habits | Overweight and Obesity | Weight Loss MaintenanceUnited States
-
University of California, San DiegoCompletedObesity | Overweight | Weight Loss | Weight MaintenanceUnited States
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedObesity | Sleep Initiation and Maintenance DisordersUnited States
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruitingUnintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking CombinUnintended Weight LossUnited States
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
Clinical Trials on Legacy Intervention
-
Vanderbilt UniversityRita & Alex Hillman FoundationCompleted
-
University of Alabama, TuscaloosaNational Institute of Nursing Research (NINR)CompletedPain | Palliative Care | Retention Disorders, Cognitive | Other Chronic IllnessUnited States
-
Children's Hospital Los AngelesETR AssociatesCompletedSexually Transmitted Diseases | Sexual Behavior | Contraception Behavior | Pregnancy PreventionUnited States
-
Medical University of South CarolinaCompleted
-
Mayo ClinicZimmer BiometCompletedTotal Knee ArthroplastyUnited States
-
CVRx, Inc.Completed
-
Venus ConceptCompleted
-
Ewha Womans UniversityCompletedOsteoarthritisKorea, Republic of
-
Starkey Laboratories, IncCompletedHearing Loss | Hearing Loss, SensorineuralUnited States